India Looks To Rebuild Shaken Confidence In Trials Industry
This article was originally published in PharmAsia News
Executive Summary
A top body representing India’s clinical research firms insists violations of drug testing norms are "isolated" and that regulatory enforcement of the sector has improved -- even as another company was rapped for defective record-keeping.